- Home
- HPK vs BLFS Comparison
HPK vs BLFS Comparison
Compare HPK & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HPK
- BLFS
- Stock Information
- Founded
- HPK 2019
- BLFS 1987
- Country
- HPK United States
- BLFS United States
- Employees
- HPK N/A
- BLFS N/A
- Industry
- HPK Oil & Gas Production
- BLFS Medical/Dental Instruments
- Sector
- HPK Energy
- BLFS Health Care
- Exchange
- HPK Nasdaq
- BLFS Nasdaq
- Market Cap
- HPK 1.1B
- BLFS 1.2B
- IPO Year
- HPK N/A
- BLFS 1989
- Fundamental
- Price
- HPK $7.26
- BLFS $25.77
- Analyst Decision
- HPK Sell
- BLFS Strong Buy
- Analyst Count
- HPK 2
- BLFS 7
- Target Price
- HPK $11.50
- BLFS $30.86
- AVG Volume (30 Days)
- HPK 405.4K
- BLFS 468.4K
- Earning Date
- HPK 11-03-2025
- BLFS 11-11-2025
- Dividend Yield
- HPK 2.18%
- BLFS N/A
- EPS Growth
- HPK N/A
- BLFS N/A
- EPS
- HPK 0.86
- BLFS N/A
- Revenue
- HPK $964,232,000.00
- BLFS $93,468,000.00
- Revenue This Year
- HPK N/A
- BLFS $26.07
- Revenue Next Year
- HPK N/A
- BLFS $16.86
- P/E Ratio
- HPK $8.43
- BLFS N/A
- Revenue Growth
- HPK N/A
- BLFS 68.16
- 52 Week Low
- HPK $7.00
- BLFS $19.10
- 52 Week High
- HPK $16.56
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- HPK 39.56
- BLFS 56.89
- Support Level
- HPK $7.41
- BLFS $25.85
- Resistance Level
- HPK $7.75
- BLFS $27.52
- Average True Range (ATR)
- HPK 0.32
- BLFS 0.76
- MACD
- HPK 0.03
- BLFS -0.03
- Stochastic Oscillator
- HPK 20.73
- BLFS 42.81
About HPK HighPeak Energy Inc.
HighPeak Energy Inc is an independent crude oil and natural gas company focused on the development of unconventional oil and natural gas reserves in Howard County of the Midland Basin. The company operates in a single segment, which is crude oil and natural gas development, exploration, and production in the U.S.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.